Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Plasma cell 1Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 151Leukemia 67Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Leukemia, Myelomonocytic, Acute 26Leukemia, Monocytic, Acute 26Myelodysplastic Syndromes 24Leukemia, Erythroblastic, Acute 23Leukemia, Megakaryoblastic, Acute 22Congenital Abnormalities 21Leukemia, Promyelocytic, Acute 13Leukemia, Myelomonocytic, Chronic 12Anemia, Refractory, with Excess of Blasts 12Recurrence 8Myeloproliferative Disorders 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Lymphoma 7Leukemia, Myeloid, Chronic-Phase 7Leukemia, Eosinophilic, Acute 7Leukemia, Biphenotypic, Acute 7Carcinoma, Hepatocellular 7Leukemia, Basophilic, Acute 6Blast Crisis 6Neoplasm, Residual 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Neutropenia 3Neoplasms, Plasma Cell 3Lymphoma, Large-Cell, Immunoblastic 3

Interventions

Cyclophosphamide 116Peripheral Blood Stem Cell Transplantation 96Filgrastim 73Etoposide 68fludarabine phosphate 61Radiotherapy 58Rituximab 57Cyclosporine 49Mycophenolic Acid 46Busulfan 44Melphalan 40Cytarabine 37Whole-Body Irradiation 36Antilymphocyte Serum 35Tacrolimus 34Methotrexate 33Vincristine 27Methylprednisolone 27Carmustine 26Prednisone 24Doxorubicin 23sargramostim 20Cord Blood Stem Cell Transplantation 18Cisplatin 17Granulocyte Colony-Stimulating Factor 15Flow Cytometry 15Ifosfamide 14Carboplatin 14Polymerase Chain Reaction 13Paclitaxel 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Lymphoma, Large-Cell, Immunoblastic × Idarubicin × Clear all
NCT00002835 2018-11-15

Combination Chemotherapy in Treating Patients With Lymphoma

M.D. Anderson Cancer Center

Phase 3 Completed
116 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

NCT00002565 2018-11-14

Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma

M.D. Anderson Cancer Center

Phase 3 Completed
61 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

NCT00002989 2009-02-09

Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 3 Unknown
207 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡